Document is current
Any future updates will be listed below
-
Authors
Xie, Jingjing http://orcid.org/0000-0002-5242-146X
He, Hao
Kong, Wenna
Li, Ziwen
Gao, Zhenting
Xie, Daoqing
Sun, Lin
Fan, Xiaofei
Jiang, Xiangqing
Zheng, Qiangang
Li, Guo
Zhu, Jidong http://orcid.org/0000-0002-1465-7244
Zhu, Guangya http://orcid.org/0000-0003-2052-4496
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (21877123)
- License Information
-
More Information
Article History
Received: 22 January 2022
Accepted: 25 August 2022
First Online: 13 October 2022
Competing interests
: J.Z. is a co-founder of Etern Biopharma. J.X., H.H., W.K., L.S., X.F., X.J., Q.Z., D.X., Z.G. and G.L. are employees of Etern Biopharma. The remaining authors declare no competing interests.
